These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 3111863)

  • 41. Mechanisms by which accessory cells contribute in growth of resting T lymphocytes initiated by OKT3 antibody.
    Palacios R
    Eur J Immunol; 1985 Jul; 15(7):645-51. PubMed ID: 3924633
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Restoration of the LFA-3 adhesion pathway in Burkitt's lymphoma cells using an LFA-3 recombinant vaccinia virus: consequences for T cell recognition.
    Griffin H; Rowe M; Murray R; Brooks J; Rickinson A
    Eur J Immunol; 1992 Jul; 22(7):1741-8. PubMed ID: 1378014
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The immune adherence receptor: dissociation between the expression of erythrocyte and mononuclear cell C3b receptors.
    Rothman IK; Gelfand JA; Fauci AS; Frank MM
    J Immunol; 1975 Nov; 115(5):1312-5. PubMed ID: 1100727
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expression of receptors for IgA on mitogen-stimulated human T lymphocytes.
    Millet I; Panaye G; Revillard JP
    Eur J Immunol; 1988 Apr; 18(4):621-6. PubMed ID: 3259188
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Induction and blocking of cytolysis in CD2+, CD3- NK and CD2+, CD3+ cytotoxic T lymphocytes via CD2 50 KD sheep erythrocyte receptor.
    Bolhuis RL; Roozemond RC; van de Griend RJ
    J Immunol; 1986 Jun; 136(11):3939-44. PubMed ID: 3084649
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Human T cells can be directed to lyse tumor targets through the alternative activation/T11-E rosette receptor pathway.
    Scott CF; Lambert JM; Kalish RS; Morimoto C; Schlossman SF
    J Immunol; 1988 Jan; 140(1):8-14. PubMed ID: 2891767
    [TBL] [Abstract][Full Text] [Related]  

  • 47. C3 cleaved by membrane proteases binds to C3b acceptors expressed on concanavalin A-stimulated human lymphocytes and enhances antibody-dependent cellular cytotoxicity.
    Erdei A; Benczur M; Fábry Z; Dierich MP; Gergely J
    Scand J Immunol; 1984 Aug; 20(2):125-31. PubMed ID: 6236547
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Behavior of soluble human 125I-labeled C3b, the third component of complement, after binding to human cells.
    Charriaut C; Barel M; Frade R
    Eur J Immunol; 1982 Apr; 12(4):289-94. PubMed ID: 6980121
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A comparative evaluation of receptor reactivities for C3b, iC3b, and C3d on Raji lymphoblastoid cells.
    Scheiner O; Hammann KP; Schmid HU; Schulz T; Alsenz J; Dierich MP
    Int Arch Allergy Appl Immunol; 1982; 69(3):231-7. PubMed ID: 6215359
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Elevated NK-mediated lysis of Raji and Daudi cells carrying fixed iC3b fragments.
    Ramos OF; Nilsson B; Nilsson K; Eggertsen G; Yefenof E; Klein E
    Cell Immunol; 1989 Apr; 119(2):459-69. PubMed ID: 2522826
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Elevated NK sensitivity of Raji cells carrying acceptor-bound C3 fragments.
    Kai C; Sármay G; Ramos O; Yefenof E; Klein E
    Cell Immunol; 1988 May; 113(2):227-34. PubMed ID: 3359489
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibition of interleukin 3 function by a fragment of the third component of complement.
    Fassbender B; Schmitt E; Bitter-Suermann D; Hadding U
    Eur J Immunol; 1987 May; 17(5):695-700. PubMed ID: 3495444
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evidence for three binding sites for C3 (hemolytically inactive), C3b and C3d on a CR2-positive Burkitt lymphoma-derived cell line (Raji).
    Barile G; Di Renzo L; Lipari M; Frati L; Faggioni A
    FEBS Lett; 1993 Jun; 324(3):319-24. PubMed ID: 8405374
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Induction of cytotoxic lymphocytes by protein A derived from Staphylococcus aureus. I. Protein-A-induced, protein-A-dependent cytotoxicity of T lymphocytes against human lymphoblastoid cell lines.
    Sumiya M; Kano S; Takaku F
    Int Arch Allergy Appl Immunol; 1982; 67(1):66-73. PubMed ID: 6976940
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The influence of C3-coated homologous erythrocytes on pokeweed-mitogen-induced polyclonal differentiation of human B cells.
    Rasmussen JM; Svehag SE
    Scand J Immunol; 1989 Aug; 30(2):209-17. PubMed ID: 2527407
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Macrophage tumor cell interaction is enhanced by C3 fragments.
    Lipari M; di Renzo L; Zicari A; Serarcangeli S; Huemer HP; Larcher C; Dierich MP; Pontieri G
    Immunobiology; 1991 Nov; 183(5):363-73. PubMed ID: 1786985
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reduced expression of HLA-DP antigens on PWM stimulated T lymphocytes in patients suffering from psoriasis vulgaris.
    Buc M; Munozová H; Russ G; Busová B; Vlcek F; Rovenský J
    Immunobiology; 1991 Mar; 182(2):197-204. PubMed ID: 1885207
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Importance of factors H and I for the adherence of C3b-coated erythrocytes to cells.
    Scheiner O; Schulz TF; Schmid HU; Lambris JD; Alsenz J; Dierich MP
    Immunobiology; 1983 Aug; 165(2):211-24. PubMed ID: 6226591
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Interactions of the third component of human complement (C3) with tumour cells: evidence for presence of C3b acceptor sites and direct activation of C3 by tumour cells.
    Daveau M; Fontaine M; Gilbert D
    Ann Immunol (Paris); 1981; 132C(3):339-50. PubMed ID: 7332319
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effector or target cell selection mediated by C3 bridges.
    Gergely J; Erdei A; Sarmay G; Klein E
    Immunol Lett; 1987 Feb; 14(3):243-8. PubMed ID: 3570362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.